Removal of melatonin receptor type 1 induces insulin resistance in the mouse

Obesity

Volumn 18, Issue 9, 2010, Pages 1861-1863

  Contreras Alcantara, Susana ^a   Baba, Kenkichi ^a   Tosini, Gianluca ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MELATONIN 1 RECEPTOR;

ANIMAL; ARTICLE; C3H MOUSE; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; GLUCOSE; INSULIN RESISTANCE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; RECEPTOR, MELATONIN, MT1;

MUS;

EID: 77956095525     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.24     Document Type: Article

References (11)

1. Dubocovich ML, Markowska M. Functional MT1 and MT2 melatoninreceptors in mammals. Endocrine 2005;27:101-110.
2. Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res2008;44:26-40.
3. Mulder H, Nagorny CL, Lyssenko V, Groop L. Melatonin receptorsin pancreatic islets: good morning to a novel type 2 diabetes gene.Diabetologia 2009;52:1240-1249.
4. Mühlbauer E, Gross E, Labucay K, Wolgast S, Peschke E. Loss ofmelatonin signalling and its impact on circadian rhythms in mouseorgans regulating blood glucose. Eur J Pharmacol 2009;606:61-71.
5. Sartori C, Dessen P, Mathieu C et al. Melatonin improves glucosehomeostasis and endothelial vascular function in high-fat diet-fedinsulin resistant mice. Endocrinology 2009;150:5311-5317
6. Lyssenko V, Nagorny CL, Erdos MR et al. Common variant in MTNR1Bassociated with increased risk of type 2 diabetes and impaired earlyinsulin secretion. Nat Genet 2009;41:82-88.
7. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C et al. A variant nearMTNR1B is associated with increased fasting plasma glucose levels andtype 2 diabetes risk. Nat Genet 2009;41:89-94.
8. Baba K, Pozdeyev N, Mazzoni F et al. Melatonin modulates visual functionand cell viability in the mouse retina via the MT1 melatonin receptor.Proc Natl Acad Sci USA 2009;106:15043-15048.
9. Duplain H, Burcelin R, Sartori C et al. Insulin resistance, hyperlipidemia,and hypertension in mice lacking endothelial nitric oxide synthase.Circulation 2001;104:342-345.
10. Cook S, Hugli O, Egli M et al. Partial gene deletion of endothelial nitricoxide synthase predisposes to exaggerated high-fat diet-induced insulinresistance and arterial hypertension. Diabetes 2004;53:2067-2072.
11. Cabou C, Cani PD, Campistron G et al. Central insulin regulates heartrate and arterial blood flow: an endothelial nitric oxide synthasedependentmechanism altered during diabetes. Diabetes 2007;56:2872-2877.